Physician profile
Stuart I Jacobs
NPI 1073574539
$3,519.93
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,895 · 2021: $205 · 2022: $500 · 2023: $659 · 2024: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874 · Education: $45.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.58 |
| Education | $45.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $1,384.35 | 2019 | |
| Abbvie INC. | $449.11 | 2019-2024 | |
| Amgen INC. | $290.27 | 2019-2023 | Otezla |
| Pfizer INC. | $258.46 | 2019-2023 | |
| Janssen Biotech, INC. | $194.85 | 2019-2024 | Tremfya, Simponi Aria, Simponi |
| Genzyme Corporation | $166.46 | 2021-2024 | |
| Galderma Laboratories, L.P. | $151.75 | 2019-2022 | |
| Genentech USA, INC. | $117.07 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $94.92 | 2022-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $85.55 | 2019-2023 | Winlevi, Absorica Ld |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.44 | 2019-2023 | Jublia |
| Incyte Corporation | $46.23 | 2022-2023 | Opzelura |
| Fresenius Kabi USA, LLC | $30.39 | 2024 | Idacio |
| Dusa Pharmaceuticals, INC. | $29.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.86 | 2023 | Spevigo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $29.32 | 2023-2024 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $28.26 | 2023 | |
| Arcutis Biotherapeutics, INC. | $19.03 | 2024 | Zoryve |
| Mayne Pharma Commercial LLC | $17.24 | 2019 | |
| Strata Skin Sciences, INC. | $16.26 | 2019 | |
| Lilly USA, LLC | $12.73 | 2019 | |
| Merck Sharp & Dohme LLC | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.